1. Home >
  2. M&A >
  3. Stake Purchase >
  4. South Africa >
  5. M2Bio Sciences Invests In Biodelta Nutraceuticals

Investment Summary

M2Bio Sciences Invests In Biodelta Nutraceuticals

On June 6, 2019, M2Bio Sciences invested in life science company Biodelta Nutraceuticals

Investment Highlights
  • This is M2Bio Sciences’ 1st transaction in the Life Science sector.
  • This is M2Bio Sciences’ 1st transaction in South Africa.

Investment Summary
Date 2019-06-06
Target Biodelta Nutraceuticals
Sector Life Science
Investor(s) M2Bio Sciences
Deal Type Stake Purchase

Target

Biodelta Nutraceuticals

Cape Town, South Africa
Biodelta Nutraceuticals, Ltd. is a manufacturer and merchandiser of premium health products to all pharmacy & health shop chains across South Africa. The company has developed, designed and produced more than 1,000 products for these customers and is now strategically positioned to launch CBD products through these channels.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

M2Bio Sciences

Cape Town, South Africa
Category Company
Sector Consumer Products
DESCRIPTION

M2Bio Sciences is a nutraceutical biotechnology company focused in the medical CBD (cannabidiol) space as well as exploring psilocybin medical health opportunities. M2Bio Sciences is based in Cape Town, South Africa.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: South Africa M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal